T cell mediated hypersensitivity to previously tolerated iodinated contrast media precipitated by introduction of atezolizumab. (2021)
Attributed to:
MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/jitc-2021-002521
PubMed Identifier: 34049931
Publication URI: http://europepmc.org/abstract/MED/34049931
Type: Journal Article/Review
Volume: 9
Parent Publication: Journal for immunotherapy of cancer
Issue: 5
ISSN: 2051-1426